Immune response to CMV in solid organ transplant recipients: current concepts and future directions (Q38011227)

26 August 2017

Immune response to CMV in solid organ transplant recipients: current concepts and future directions (English)

1 reference

26 August 2017

Richard R Watkins

1

1 reference

PubMed ID

22607184

26 August 2017

Tracy L Lemonovich

series ordinal

2

1 reference

PubMed ID

22607184

26 August 2017

Raymund R Razonable

series ordinal

3

1 reference

26 August 2017

1 May 2012

1 reference

Expert Review of Clinical Immunology

26 August 2017

1 reference

26 August 2017

8

1 reference

26 August 2017

4

1 reference

26 August 2017

383-393

1 reference

Cytomegalovirus seroprevalence in the United States: the national health and nutrition examination surveys, 1988-2004.

26 August 2017

1 reference

Broadly targeted human cytomegalovirus-specific CD4+ and CD8+ T cells dominate the memory compartments of exposed subjects

21 January 2018

1 reference

Infection in solid-organ transplant recipients

21 January 2018

1 reference

Prevention of posttransplant cytomegalovirus disease and related outcomes with valganciclovir: a systematic review

21 January 2018

1 reference

Cytomegalovirus: pathogen, paradigm, and puzzle

21 January 2018

1 reference

Influence of cytomegalovirus disease in outcome of solid organ transplant patients.

21 January 2018

1 reference

Infection in organ-transplant recipients

21 January 2018

1 reference

Revisiting the effects of CMV on long-term transplant outcome

21 January 2018

1 reference

Antigen-driven effector CD8 T cell function regulated by T-bet

21 January 2018

1 reference

Primary cytomegalovirus phosphoprotein 65-specific CD8+ T-cell responses and T-bet levels predict immune control during early chronic infection in lung transplant recipients

21 January 2018

1 reference

Molecular profiling of cytomegalovirus-induced human CD8+ T cell differentiation

21 January 2018

1 reference

Current concepts on cytomegalovirus infection after liver transplantation

21 January 2018

1 reference

Virologic and immunologic monitoring of cytomegalovirus to guide preemptive therapy in solid-organ transplantation.

21 January 2018

1 reference

Monitoring human cytomegalovirus infection in transplant recipients

21 January 2018

1 reference

Improving outcomes for solid-organ transplant recipients at risk from cytomegalovirus infection: late-onset disease and indirect consequences

21 January 2018

1 reference

Protection from cytomegalovirus after transplantation is correlated with immediate early 1-specific CD8 T cells

21 January 2018

1 reference

Cell-mediated immunity to predict cytomegalovirus disease in high-risk solid organ transplant recipients.

21 January 2018

1 reference

Therapeutic effect of the acquisition of cytomegalovirus-specific immune response during preemptive treatment.

21 January 2018

1 reference

Polyfunctional cytomegalovirus-specific immunity in lung transplant recipients receiving valganciclovir prophylaxis

21 January 2018

1 reference

A prospective longitudinal analysis of cytomegalovirus (CMV)-specific CD4+ and CD8+ T cells in kidney allograft recipients at risk of CMV infection

21 January 2018

1 reference

Monitoring of cytomegalovirus-specific CD8+ T-cell response with major histocompatibility complex pentamers in kidney transplant recipients.

21 January 2018

1 reference

Dendritic-cell control of pathogen-driven T-cell polarization

21 January 2018

1 reference

Programmed death-1 receptor and interleukin-10 in liver transplant recipients at high risk for late cytomegalovirus disease

21 January 2018

1 reference

Predominant Th1 and cytotoxic phenotype in biopsies from renal transplant recipients with transplant glomerulopathy.

21 January 2018

1 reference

Levels of virus-specific CD4 T cells correlate with cytomegalovirus control and predict virus-induced disease after renal transplantation

21 January 2018

1 reference

Cytomegalovirus infection after liver transplantation: current concepts and challenges

21 January 2018

1 reference

Cytomegalovirus-specific T-cell responses and viral replication in kidney transplant recipients

21 January 2018

1 reference

T cell control of primary and latent cytomegalovirus infections in healthy subjects.

21 January 2018

1 reference

Role of CMV in immune senescence

21 January 2018

1 reference

CD4+ T cells and immunosenescence--a mini-review

21 January 2018

1 reference

Immunosenescence increases the rate of acceptance of kidney allotransplants in elderly recipients through exhaustion of CD4+ T-cells.

21 January 2018

1 reference

Clinical utility of cytomegalovirus (CMV) serology testing in high-risk CMV D+/R- transplant recipients

21 January 2018

1 reference

Donor and recipient CMV serostatus and antigenemia after renal transplantation: an analysis of 486 patients

21 January 2018

1 reference

Non-organ-specific and anti-endothelial antibodies in relation to CMV infection and acute rejection in renal transplant recipients

21 January 2018

1 reference

Peptides from cytomegalovirus UL130 and UL131 proteins induce high titer antibodies that block viral entry into mucosal epithelial cells

21 January 2018

1 reference

Homozygosity for the toll-like receptor 2 R753Q single-nucleotide polymorphism is a risk factor for cytomegalovirus disease after liver transplantation

21 January 2018

1 reference

A comprehensive genotype-phenotype interaction of different Toll-like receptor variations in a renal transplant cohort.

21 January 2018

1 reference

21 January 2018

1 reference

Natural killer cell receptor repertoire and their ligands, and the risk of CMV infection after kidney transplantation

21 January 2018

1 reference

CMV infection is associated with the depletion but lack of activation of peripheral blood natural killer cells in a lung transplant cohort

21 January 2018

1 reference

Imprint of human cytomegalovirus infection on the NK cell receptor repertoire

21 January 2018

1 reference

Expansion of CD94/NKG2C+ NK cells in response to human cytomegalovirus-infected fibroblasts.

21 January 2018

1 reference

Expansion of a unique CD57⁺NKG2Chi natural killer cell subset during acute human cytomegalovirus infection

21 January 2018

1 reference

Ex vivo monitoring of human cytomegalovirus-specific CD8+ T-cell responses using QuantiFERON-CMV.

21 January 2018

1 reference

Linking CMV serostatus to episodes of CMV reactivation following lung transplantation by measuring CMV-specific CD8+ T-cell immunity

21 January 2018

1 reference

Quantiferon-CMV test in prediction of cytomegalovirus infection after kidney transplantation.

21 January 2018

1 reference

Immune functional assay for immunosuppressive management in post-transplant malignancy

21 January 2018

1 reference

Recovery of functional memory T cells in lung transplant recipients following induction therapy with alemtuzumab

21 January 2018

1 reference

"Immuknow" to measurement of cell-mediated immunity in renal transplant recipients undergoing short-term evaluation

21 January 2018

1 reference

Monitoring of CD38high expression in peripheral blood CD8+ lymphocytes in patients after kidney transplantation as a marker of cytomegalovirus infection.

21 January 2018

1 reference

Immunocompromised hosts: perspectives in the treatment and prophylaxis of cytomegalovirus disease in solid-organ transplant recipients

21 January 2018

1 reference

Valganciclovir prophylaxis versus preemptive therapy in cytomegalovirus-positive renal allograft recipients: 1-year results of a randomized clinical trial

21 January 2018

1 reference

Preemptive versus prophylactic protocol to prevent cytomegalovirus infection after renal transplantation: a meta-analysis and systematic review of randomized controlled trials

21 January 2018

1 reference

Primary response against cytomegalovirus during antiviral prophylaxis with valganciclovir, in solid organ transplant recipients

21 January 2018

1 reference

Impact of a polymorphism in the IL-12p40 gene on the outcome of kidney transplantation.

21 January 2018

1 reference

Association between a polymorphism in the human programmed death-1 (PD-1) gene and cytomegalovirus infection after kidney transplantation

21 January 2018

1 reference

Vaccine prevention of maternal cytomegalovirus infection

21 January 2018

1 reference

Cytomegalovirus glycoprotein-B vaccine with MF59 adjuvant in transplant recipients: a phase 2 randomised placebo-controlled trial

21 January 2018

1 reference

Human cytomegalovirus serum neutralizing antibodies block virus infection of endothelial/epithelial cells, but not fibroblasts, early during primary infection.

21 January 2018

1 reference

Isolation of human monoclonal antibodies that potently neutralize human cytomegalovirus infection by targeting different epitopes on the gH/gL/UL128-131A complex

21 January 2018

1 reference

Cytomegalovirus vaccines fail to induce epithelial entry neutralizing antibodies comparable to natural infection

21 January 2018

1 reference

Immune-based therapies for cytomegalovirus infection

21 January 2018

1 reference

Recombinant glycoprotein B vaccine formulation with Toll-like receptor 9 agonist and immune-stimulating complex induces specific immunity against multiple strains of cytomegalovirus.

21 January 2018

1 reference

Delineating the role of CD4+ T cells in the activation of human cytomegalovirus-specific immune responses following immunization with Ad-gBCMVpoly vaccine: implications for vaccination of immunocompromised individuals.

21 January 2018

1 reference

Cytomegalovirus immunoglobulin decreases the risk of cytomegalovirus infection but not disease after pediatric lung transplantation

21 January 2018

1 reference

Cytomegalovirus prevention and long-term recipient and graft survival in pediatric heart transplant recipients

21 January 2018

1 reference

The association between cytomegalovirus immune globulin and long-term recipient and graft survival following liver transplantation

21 January 2018

1 reference

Adoptive T-cell therapy of a lung transplanted patient with severe CMV disease and resistance to antiviral therapy

21 January 2018

1 reference

Induction of antiviral cytotoxic T cells by plasmacytoid dendritic cells for adoptive immunotherapy of posttransplant diseases.

21 January 2018

1 reference

Significant association of multiple human cytomegalovirus genomic Loci with glioblastoma multiforme samples

21 January 2018

1 reference

Cytomegalovirus-induced gammadelta T cells associate with reduced cancer risk after kidney transplantation

21 January 2018

1 reference

Antibody-dependent anti-cytomegalovirus activity of human γδ T cells expressing CD16 (FcγRIIIa).

21 January 2018

1 reference

Impact of prophylactic versus preemptive valganciclovir on long-term renal allograft outcomes

21 January 2018

1 reference

Human CMV infection induces 5-lipoxygenase expression and leukotriene B4 production in vascular smooth muscle cells

21 January 2018

1 reference

Influence of human cytomegalovirus infection on the NK cell receptor repertoire in children

21 January 2018

1 reference

Combined CMV Prophylaxis Improves Outcome and Reduces the Risk for Bronchiolitis Obliterans Syndrome (BOS) after Lung Transplantation

21 January 2018

1 reference

Clinical Utility of Cytomegalovirus Cell-Mediated Immunity in Transplant Recipients With Cytomegalovirus Viremia

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1586/ECI.12.25

1 reference

26 August 2017

1 reference

PubMed ID

22607184